← back to search

Adrian D. Hrabar

Clinical Research Institute ·
Area of research
Surgery · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Lipoproteins and Cardiovascular Health, Atrial Fibrillation Management and Outcomes, Cardiovascular and exercise physiology, and Coronary Artery Anomalies.
h-index
16
citations
6,449
works
29
NIH funding
primary concept
Medicine
email

Recent publications

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
The Lancet Infectious Diseases 2021cited by 172position: middledoi
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
The Lancet 2019cited by 2,975position: middledoi
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
The Lancet 2019cited by 620position: middledoi
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
The Lancet 2017cited by 875position: middledoi
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
The Lancet 2017cited by 752position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

No co-authors indexed yet.